Sept 12, 2019 –
“Drug manufacturers cannot, as is alleged here, knowingly seek out suspect doctors and pharmacies, oversupply them with opioids for the purpose of diversion, benefit from the process, and then cynically invoke their status as otherwise lawful companies to avoid civil liability,” Appellate Judge D. Michael Swiney wrote. The common perception of a drug dealer may be that of the street dealer, but the DDLA does not make that distinction,” the opinion continued. “If plaintiffs’ allegations are correct … (opioid) manufacturer defendants knowingly flooded the affected areas with drugs they knew were to be diverted. “That is the basis for civil liability under the DDLA whether one’s headquarters is an office building or a back alley,” the court ruled.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…